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The mammalian translocon-associated protein (TRAP) complex
comprises four transmembrane protein subunits in the endoplas-
mic reticulum. The complex associates with the Sec61 translocon,
although its function in vivo remains unknown. Here, we show
the involvement of the TRAP complex in endoplasmic reticulum-
associated degradation (ERAD). All four subunits are induced
simultaneously by endoplasmic reticulum stresses from the
X-box-binding protein 1/inositol-requiring 1a pathway. RNA
interference knockdown of each subunit causes disruption of
the native complex and significant delay in the degradation of
various ERAD substrates, including the a1-antitrypsin null Hong
Kong variant (NHK). In a pulse-chase experiment, the TRAP
complex associated with NHK at a late stage, indicating its
involvement in the ERAD pathway rather than in biosynthesis of
nascent polypeptides in the endoplasmic reticulum. In addition,
the TRAP complex bound preferentially to misfolded proteins
rather than correctly folded wild-type substrates. Thus, the TRAP
complex induced by the unfolded protein response pathway
might discriminate ERAD substrates from correctly folded
substrates, accelerating degradation.
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INTRODUCTION
Secretory and membrane proteins are synthesized in the
endoplasmic reticulum (ER), in which they are folded and
processed or modified into mature proteins. In the ER, a quality
control system ensures that only proteins that are folded and
processed correctly enter the secretory pathway (Ellgaard &
Helenius, 2003). When misfolded proteins accumulate in the ER
of mammalian cells, the following four quality control processes
operate successively through the activation of unfolded protein
response pathways (Rutkowski & Kaufman, 2004): (i) activated
PKR-related ER kinase (PERK) phosphorylates the a-subunit of
eukaryotic translation initiation factor 2, thus inhibiting translation
and preventing accumulation of additional misfolded proteins;
(ii) activation of the activating transcription factor (ATF)6 pathway
upregulates ER chaperones such as immunoglobulin heavy chain
binding protein (BiP) and calreticulin, thus promoting refolding
of misfolded proteins; (iii) induction of the X-box-binding
protein 1/inositol-requiring 1a (XBP1/IRE1a) pathway produces
ER-associated degradation (ERAD) components such as ER
degradation-enhancing a-mannosidase-like protein (EDEM;
Hosokawa et al, 2001), thus promoting degradation of terminally
misfolded proteins; and (iv) selective translation of ATF4 results in
apoptosis of cells failing to overcome severe ER stress.
The ERAD system for misfolded glycoproteins (Meusser et al,
2005; Romisch, 2005) is the best understood of these four
responses and comprises three essential processes: (i) recognition
of misfolded proteins to be degraded by lectin-like molecules;
(ii) retrograde transport of misfolded proteins from the ER to the
cytosol through translocating channels; and (iii) degradation of
misfolded proteins by the ubiquitin–proteasome system. Despite
recent improvements in our knowledge of the ERAD system, many
of its underlying mechanisms remain poorly understood.
As many factors in ER quality control are induced by ER stress,
we attempted to identify novel genes induced specifically by
tunicamycin treatment, which inhibits N-linked glycosylation and
results in protein misfolding, leading to ER stress. By using
suppression subtractive hybridization (Diatchenko et al, 1996)
before and after tunicamycin treatment, we isolated about 20
genes—the functions of which under the ER stress response are
still unknown—with42-fold induction after ER stress from 480 clones
(the screening strategy is shown in supplementary Fig 1 online).
We focused our analysis on the translocon-associated protein
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(TRAP) complex g-subunit. The four-subunit TRAP complex
localizes in the ER membrane, associating with the Sec61
translocon as a heterotetramer (Hartmann et al, 1993; Menetret
et al, 2005). The a-, b- and d-subunits contain a single ER
transmembrane region, whereas the g-subunit spans the membrane
four times. A large part of each subunit localizes to the ER lumen.
Here, we show the simultaneous induction of all four subunits
of the TRAP complex by ER stresses from the XBP1/IRE1a pathway,
and its involvement in the acceleration of misfolded protein ERAD
by discriminating them from correctly folded proteins.
RESULTS AND DISCUSSION
In mouse BALB/c 3T3 cells, ER stress induced TRAPg messenger
RNA, whereas cytosolic stress did not (supplementary Fig 2
online). ER stress also induced mRNA synthesis (supplementary
Fig 2A online) and protein synthesis (data not shown) of other
TRAP complex subunits. After treatment of BALB/c 3T3 cells with
tunicamycin, the transcription of genes encoding all four subunits
was induced simultaneously (Fig 1A), suggesting a common
signalling pathway for induction.
As either the ATF6 or the XBP1/IRE1a pathways might regulate
transcription of TRAP subunits, we examined their induction in
IRE1aþ /þ and IRE1a/ mouse embryonic fibroblast (MEF) cells
(Lee et al, 2002) by using northern hybridization (Fig 1B). BiP,
an ATF6-pathway-induced ER-resident molecular chaperone, is
induced in both IRE1aþ /þ and IRE1a/ MEF cells after
tunicamycin treatment (Lee et al, 2002; Yoshida et al, 2003). By
contrast, IRE1a knockout resulted in almost complete abolition of
TRAP complex mRNA induction after ER stress (Fig 1B), indicating
that transcription of all four TRAP subunits is induced by the
XBP1/IRE1a pathway. This is the first demonstration that ER stress
results in simultaneous induction of all subunits in the functional
complex, and also in induction by the XBP1/IRE1a pathway.
Moreover, the b-subunit of Sec61 translocon was induced at a low
level under ER stress conditions (data not shown), and a- and
g-subunits of Sec61 translocon were also reported to be induced
during plasma cell differentiation by the XBP1 pathway (Shaffer
et al, 2004). These observations indicate the possibility that Sec61
translocon and the TRAP complex are simultaneously upregulated
by the unfolded protein response pathway.
Many ERAD components are reported to be induced by the
XBP1/IRE1a pathway (Yoshida et al, 2003; Oda et al, 2006), and
thus it is possible that the TRAP complex might also be involved in
the ERAD pathway. Therefore, we carried out RNA interference
(RNAi) knockdown by using short hairpin RNAs (shRNAs) to
investigate the function of the TRAP complex in vivo. We
proposed that knockdown of one subunit would disrupt formation
of the TRAP complex, inhibiting its function. Treatment with
shRNAs targeted to each of the subunits, with the exception of the
TRAPd subunit, specifically and effectively depleted target mRNAs
in human embryonic kidney (HEK) 293 cells (Fig 2A; supplemen-
tary Fig 3 online). Two independent shRNA constructs for the
TRAPd subunit failed to effect efficient knockdown. None of the
shRNAs affected transcription of non-target TRAP subunit genes
(Fig 2A). Western blot analysis showed that TRAPa levels were
reduced according to the reduction of TRAPa mRNA (Fig 2B).
Surprisingly, TRAPa levels were also reduced in cells transfected
with shRNAs for TRAPb or TRAPg subunits, whereas mRNA levels
remained unaffected. Similar results were also observed for TRAPd
(Fig 2B). Knockdown of TRAP subunits did not affect the
abundance of Sec61b, calnexin or b-actin (Fig 2B). As these
results indicated that formation of a native TRAP complex might
be affected by missing subunits, we carried out blue-native–
polyacrylamide gel electrophoresis (BN–PAGE; Wang & Dobber-
stein, 1999) on microsomal fractions prepared by treatment with
3% digitonin from cells expressing a specific shRNA. The
abundance of native TRAP complex (150 kDa) was reduced on
knockdown of the a-, b- or g-subunits, whereas it remained
unchanged by treatment with the negative controls, that is,
nonspecific RNAi or TRAPd subunit shRNA (Fig 2C). Conversely,
RNAi of TRAP subunits effected no change in the abundance of
the Sec61 complex (140 kDa and 280 kDa; Fig 2C). Thus,
depletion of the a-, b- or g-subunits resulted in disruption of the
native TRAP complex, and TRAP components that were not
included in the complex might be degraded (Fig 2B).
As ER stress induced all TRAP components by the XBP1/IRE1a
pathway, we examined its possible involvement in ERAD. The null
Hong Kong variant (NHK) of a1-antitrypsin (a1AT), a serine
protease inhibitor secretory protein (Sifers et al, 1988; Hosokawa
et al, 2001), was used as the substrate for ERAD. In pulse–chase
experiments, we observed substantial delays in NHK degradation,
if any of the TRAP components (a, b or g) were depleted by RNAi
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Fig 1 | Endoplasmic reticulum stress causes simultaneous induction of
each TRAP complex subunit by the X-box-binding protein 1/inositol-
requiring 1a pathway. (A) Total RNA was isolated from BALB/c 3T3 cells
treated with 5 mgml1 tunicamycin for the periods indicated. RNA (5mg)
was analysed by northern hybridization using complementary DNA
probes specific to each subunit of mouse TRAP (a, b, g and d), mouse
BiP (induced by endoplasmic reticulum stress) and human GAPDH
(loading control). (B) Wild-type MEF cells (þ /þ ) or IRE1a-knockout
MEF cells (/) were treated with 5mgml1 tunicamycin for 12 h,
followed by northern blot analysis. BiP, immunoglobulin heavy chain
binding protein; GAPDH, glyceraldehydes-3-phosphate dehydrogenase;
IRE, inositol-requiring; MEF, mouse embryonic fibroblast; TRAP,
translocon-associated protein.
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(Fig 3A,B), indicating involvement of the complex in NHK ERAD.
As knockdown of the d-subunit was unsuccessful, no delay in
NHK degradation was observed and it represented an additional
negative control. RNAi of TRAP components did not affect the
rates of cellular clearance and secretion into the medium or
glycosylation of wild-type a1AT (Fig 3A,B). To exclude the
possibility that the delay of NHK degradation by TRAP RNAi was
caused by an indirect effect such as ER disturbance owing to the
decrease in the abundant ER membrane proteins, we knocked
down another ER membrane protein, ribophorin I. After knock-
down of ribophorin I, a partly glycosylated band of NHK was
observed because ribophorin I is one of the subunits of
oligosaccharyltransferase (supplementary Fig 4A online). How-
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Fig 2 | RNA intereference knockdown of each TRAP subunit disrupts the native TRAP complex in the endoplasmic reticulum. Human embryonic
kidney 293 cells were transfected with short hairpin RNA expression vectors against each of the TRAP subunits (pSUPER-a1(a), pSUPER-b1(b),
pSUPER-g1(g) and pSUPER-d1(d)) or a nonspecific sequence (pSUPER-NS (NS)). (A) Northern blot analysis of each TRAP subunit after RNAi
treatment. Total RNA (10mg) was used for detection, as described in Fig 1, using probes specific to human TRAP subunits. (B) Western blot analysis
of each TRAP subunit after RNAi treatment. Cellular proteins were extracted in NP-40 lysis buffer, and each protein was detected by western blotting.
(C) BN–PAGE analysis of the TRAP complex after RNAi treatment. Microsomal fractions (10 or 2mg protein) were separated by 5–18% BN–PAGE and
detected with TRAPa antibody or Sec61b antibody, respectively. Calnexin was used as the loading control (1mg of sample). The amounts of native
TRAP complex remaining after RNAi treatment of each subunit were quantified from three independent analyses and are shown at the bottom of the
left panel. The amount of native TRAP complex in the NS lane was set to 100%. BN–PAGE, blue-native–polyacrylamide gel electrophoresis;
IB, immunoblotting; RNAi, RNA interferene; TRAP, translocon-associated protein.
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even after ribophorin I knockdown when compared with
nonspecific RNAi (supplementary Fig 4B,C online). These data
clearly indicated that the effect on NHK was not caused by
an artefact such as disturbance of the ER membrane.
To find other soluble and transmembrane ERAD substrates, we
investigated the degradation of a carboxy-terminal-truncated soluble
form of ribophorin I (RI332; Fig 3C; de Virgilio et al, 1998) and the T-cell
receptor a-subunit (TCRa; Fig 3D; Yu et al, 1997), after RNAi depletion
of TRAP subunits. Degradation of RI332 and TCRa was slowed
substantially (i.e., half-lives were doubled) after knockdown of the
TRAPg subunit (Fig 3C,D). This supports the suggestion that the TRAP
complex is involved in the degradation of various ERAD substrates.
We analysed the interaction between the TRAP complex and
misfolded ERAD substrates by using immunoprecipitation. Cells
were lysed in 3% digitonin, and substoichiometric ratios of all four
subunits of the endogenous TRAP complex were immunoprecipi-
tated with TRAPa antibody (supplementary Fig 5 online; Hartmann
et al, 1993). Using TRAPa antibody as the first immunoprecipita-
tion, we carried out a sequential immunoprecipitation with a1AT
antibody and observed co-immunoprecipitation of endogenous
TRAP complex with NHK (Fig 4A, lane 15). This indicates that the
ERAD substrate (NHK) is bound to the TRAP complex. Moreover,
overexpressed TRAPa–HA (haemagglutinin) and NHK interacted
with each other, as shown by co-immunoprecipitation in the
presence of 1% NP-40 (supplementary Fig 6A online). Under this
condition, subunits of the TRAP complex dissociated and Sec61
translocon also dissociated from the TRAP complex (supplementary
Fig 6B online). This indicates that the observed co-immunopreci-
pitation of NHK and TRAP might reflect direct binding.
Next, we examined the interaction of the TRAP complex with
NHK and wild-type a1AT, which is assumed to be folded correctly
in the ER, and observed co-immunoprecipitation of endogenous
TRAP complex with the former only (Fig 4B, lanes 7 and 9,
respectively). In addition, there was only a slight increase in co-
immunoprecipitation of wild-type a1AT and the TRAP complex
even after secretion of the former was inhibited by osmotic stress
(0.6M sorbitol; supplementary Fig 7 online). NHK was co-
immunoprecipitated with the TRAP complex in both the presence
and absence of sorbitol (supplementary Fig 7 online), indicating
that preferential binding of TRAP to NHK was not merely because
NHK was retained in the ER for a longer time.
As the TRAP complex has been reported to accelerate
substrate-dependent ER membrane translocation of secretory
proteins from the cytosol (Fons et al, 2003), we examined whether
it interacts with substrates during import into the ER, or with
retrograde transport from the ER to the cytosol. We carried out
a pulse–chase experiment combined with immunoprecipitation
analysis in the presence or absence of lactacystin—a proteasome
inhibitor. Little interaction between TRAP and NHK could be
detected immediately after pulse labelling, whereas it increased
substantially during the chase period (Fig 5A). At 1 h and 2 h of
chase, the ratio [TRAP-bound NHK]/[total NHK] increased two-
and fourfold, respectively (Fig 5B). In the presence of lactacystin,
in which NHK degradation was inhibited, the abundance of
bound NHK was much higher than in the absence of lactacystin
(Fig 5A, compare lanes 5 and 3). In the presence of lactacystin, the
ratio of TRAP-bound NHK to total NHK was also higher after a 2 h
chase period compared with that immediately after pulse-labelling
(compare lanes 5 and 4). We also quantified calnexin binding
of NHK during the chase period. As clearly shown in Fig 5, the
binding of NHK to calnexin was rapidly decreased during the
chase period, whereas binding to the TRAP complex increased
(Fig 5B), indicating that NHK binds to TRAP after it is released
from calnexin. These results strongly indicate that the TRAP
complex interacts with misfolded ERAD substrates at a late
stage—that is, during protein dislocation from the ER and not
during import across the ER membrane. Thus, TRAP is necessary
for efficient ERAD, discriminating misfolded proteins from
correctly folded proteins. Co-immunoprecipitation analysis using
the whole-cell lysate of HEK 293 cells showed weak (possibly
transient) interaction of the TRAP complex and calnexin (supple-
mentary Fig 8 online), which is consistent with previous reports
(Wada et al, 1991; Fons et al, 2003). Co-immunoprecipitation
analysis of the TRAP complex also showed interaction with p97
and EDEM1, which are involved in the ERAD machinery, to an
extent similar to that with calnexin, whereas interaction of the
TRAP complex with BiP was weaker (supplementary Fig 8 online).
As TRAP was first reported to be a transmembrane protein complex
that associates with the Sec61 translocon (Hartmann et al, 1993;
Menetret et al, 2005), its function in ERAD might be to recruit
misfolded proteins to the Sec61 translocon in the ER membrane.
Both the Sec61 translocon (Pilon et al, 1997; Plemper et al,
1997) and the Derlin complex (Ye et al, 2004) have been
proposed as dislocation channels for the transfer of misfolded
proteins from the ER to the cytosol. In mammalian cells, Sec61
comprises three subunits (Sec61a, Sec61b and Sec61g), all of
which are ER transmembrane proteins, the first subunit spanning
the ER membrane ten times to create the translocation channel
(Menetret et al, 2005). Electron microscopic observation of the
mammalian Sec61 complex, and also X-ray analysis of the SecY
complex from archaebacterium Methanococcus jannaschii, in-
dicates that the channel pore is too narrow for translocation of
folded and/or glycosylated proteins (Van den Berg et al, 2004;
Menetret et al, 2005). Conversely, analysis of the crystal structure
of the archaeal SecY complex indicated that some transmembrane
components of translocon are flexible, allowing the channel to
open to the hydrophobic lipid bilayers of the membrane (Van den
Berg et al, 2004). This might allow the retrotranslocation of
Fig 3 | Knockdown of the TRAP complex delays endoplasmic reticulum-associated degradation of misfolded glycoproteins. Human embryonic kidney
293 cells were transiently co-transfected with plasmids encoding endoplasmic reticulum-associated degradation substrates and short hairpin RNA
(pSUPER-NS, pSUPER-a1, pSUPER-b1, pSUPER-g1 or pSUPER-d1). Degradation of the substrates was examined by metabolic labelling with
[35S]Met/Cys for 15min and by chasing with normal growth medium for the time periods indicated. Intracellular substrates were detected by
immunoprecipitation. (A) Degradation of the null Hong Kong (NHK) variant and secretion of wild-type a1-antitrypsin, (C) degradation of the
C-terminal-truncated soluble form of ribophorin-1 (RI332) and (D) degradation of the T-cell receptor a-subunit (TCRa) are shown. Quantification
analyses of these are shown in (B–D). Radioactivity at chase¼ 0 h was set to 100%, and relative radioactivity compared with this value is shown in
the graph. The averages of five (for NHK), four (for wt a1AT) and three (for RI332 and TCRa) independent experiments are plotted and error bars
represent s.e.m. CHO refers to N-linked glycan. HA, Haemagglutinin; Med, medium; wt a1AT, wild-type a1-antitrypsin.
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misfolded ERAD substrates. Recently, a Sec61 dimer was reported
to assemble into a tetramer, which associated with two TRAP
complexes (Menetret et al, 2005). Further investigation is required
to determine whether the TRAP complex is involved in the
regulation of supramolecular translocon complex formation, the
dynamic structure of the channel and/or its pore size.
Mammalian Derlin-1 has recently been implicated in the US11-
mediated retrotranslocation of the class I major histocompatibility
complex heavy chain (Lilley & Ploegh, 2004; Ye et al, 2004),
providing the missing link between ER luminal events and those in
the cytosol. Although it was proposed that Derlin-1 formed a
retrotranslocation channel (Ye et al, 2004), we have no direct
evidence to confirm this hypothesis. It has also been reported that
proteasomes bind directly to the Sec61 complex (Kalies et al, 2005),
supporting the idea that misfolded proteins are retrotranslocated
from the ER to the cytosol through this translocon. Thus, at present,
it seems that we are far from any conclusive determination of the
retrotranslocation channels working with the ERAD pathway.
In mammalian cells, the XBP1/IRE1a pathway induces certain
molecules—for example, EDEMs (1–3) HMG-CoA reductase
degradation (HRD)1 and Derlins (1–3), and all of these factors are
related to the ERAD pathway (Yoshida et al, 2003; Oda et al, 2006).
The results of this study show that the four TRAP complex subunits
are possible ERAD factors induced by the XBP1/IRE1a pathway,
and provide strong supportive evidence that ERAD substrates are
committed to and retrotranslocated through the Sec61 translocon.
METHODS
Plasmid construction for RNA interference. pSUPER (Oligo-
Engine, Seattle, WA, USA) was used to deliver shRNAs. Three
independent 19 bp target sequences were designed against each
TRAP subunit, and the shRNA sequence for nonspecific RNAi was
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Fig 4 | The endogenous TRAP complex preferentially binds to misfolded
endoplasmic reticulum-associated degradation substrates. (A) Co-
immunoprecipitation (co-IP) of the endogenous TRAP complex with
NHK. HEK 293 cells were transfected with NHK (þ ) or mock plasmid
(), then radiolabelled with [35S]Met/Cys for 2 h, followed by disruption
in 3% digitonin lysis buffer. The first IP was carried out with (T) or
without () TRAPa antibody, and eluates were then subjected to a
second IP using a1AT (A), TRAPa antibodies (T) or only protein A
beads as a control (). To detect NHK and the endogenous TRAPa by
IP, one-fifth of the volume of the cell lysate used for co-IP was applied
to each lane (lanes 1–4). (B) Comparison of the affinity of the TRAP
complex for NHK and wild-type a1AT. The second IPs were carried out
with (þ ) or without () a1AT antibody (upper panel, lanes 4–9), or
with TRAPa antibody (lower panel, lanes 13–15). Control IPs were
carried out using a1AT (lanes 1–3) and TRAPa (lanes 10–12) antibodies.
a1AT, a1-antitrypsin; HEK, human embryonic kidney; IP,
immunopreipitation; Met/Cys, methionine/cysteine; NHK, null Hong
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Fig 5 | The null Hong Kong variant is co-immunoprecipitated with the
TRAP complex during the chase period. (A) Intracellular NHK levels
(upper panel) and NHK co-immunoprecipitated with the endogenous
TRAP complexes (middle panel) or calnexin (lower panel) in HEK 293
cells transfected with NHK in the presence (þ ) or absence () of
lactacystin. The pulse–chase experiment was carried out as in Fig 3, and
the time course of NHK degradation and interaction with the TRAP
complex was analysed by IP or sequential IP as described in Fig 4A.
(B) Quantification of NHK co-IP with TRAP (grey bars) or calnexin
(white bars) relative to total NHK. The values at chase¼ 0 h were set as
1 for TRAP-associated (left vertical axis) and calnexin-associated NHK
(right vertical axis). The averages of three independent experiments are
plotted and error bars indicate s.e.m. (n¼ 3). HEK, human embryonic
kidney; IP, immunoprecipitation; NHK, null Hong Kong variant; TRAP,
translocon-associated protein.
TRAP complex involvement in ERAD pathway
K. Nagasawa et al
EMBO reports VOL 8 | NO 5 | 2007 &2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
scientificreport
488
Piscataway, NJ, USA). To analyse RNAi efficiency using northern
hybridization, HEK 293 cells were transfected with pSUPER-
expressing constructs or nonspecific shRNA (pSUPER-NS); two
constructs were chosen for each subunit. Target sequences are
indicated in supplementary Fig 3A online.
Metabolic labelling, immunoprecipitation and blue-native–poly-
acrylamide gel electrophoresis. HEK 293 cells were radiola-
belled with [35S]-EXPRESS protein labelling mixture (PerkinElmer,
Life and Analytical Sciences Inc., Wellesley, MA, USA) and
chased in normal DMEM/10% fetal bovine serum. Cellular
proteins were extracted with 1% NP-40 lysis buffer (50mM
Tris–HCl (pH 7.4), 150mM NaCl, 1% NP-40 and protease
inhibitors (1 mgml1 leupeptin, 1 mgml1 pepstatin A, 2mM
N-ethylmaleimide and 0.2mM AEBSF)) or 3% digitonin (Calbio-
chem, EMD Biosciences Inc., Darmstadt, Germany) lysis buffer.
For sequential immunoprecipitation, immune complexes were
released from beads by boiling in elution buffer (50mM Tris–HCl
(pH 7.4), 150mM NaCl, 1% NP-40, 2% SDS and protease
inhibitors) for 10min. Supernatants were collected and diluted in
NP-40 lysis buffer until the final concentration of SDS reached
0.1%. The second immunoprecipitation was carried out using
1% NP-40 as the detergent. Sample preparation and separation
by BN–PAGE was carried out as described previously (Wang
& Dobberstein, 1999).
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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